EUCTR2014-005077-36-SE进行中（未招募）1 期
Simplified basic immunisation after transplantation of stem cells
Örebro Läns Landsting0 个研究点目标入组 50 人开始时间: 2015年1月29日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Patients who have undergone allogeneic or autologous stem cell transplantation
- •Male or female > 18 years old
- •Patients who have given written consent to participate in the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 40
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 10
排除标准
- •Pregnancy confirmed / suspected by the patient upon request.
- •Allergy or hypersensitivity to any of the vaccine constituents.
- •Ongoing acute illness (temperature >38 degrees celsius).
- •Other immunosuppressive disease or ongoing immunosuppressive therapy for other disease than GVH.
- •Recurrence of malignancy.
- •Treatment with rituximab in the last 6 months.
- •Alcohol abuse.
- •Mental retardation
- •If the investigator for any other reason determines that the patient is not suitable to be included.
研究者
相似试验
进行中（未招募）
1 期
Supplementary immunization after hematopoietic stem cell transplantation for patients not reponding at M3.Our aim is to determine whether an additional dose of inactivated vaccine can increase the rate of responders among patients who have not responded adequately after 3 injectionsMedDRA version: 20.0Level: LLTClassification code 10067859Term: Allogenic stem cell transplantationSystem Organ Class: 100000004865EUCTR2017-003523-30-FRniversity Hospital Grenoble200
进行中（未招募）
1 期
A randomised controlled trial of regulatory immune cells (Tregs) to allow reduction of immunosuppression following renal transplantation.EUCTR2017-001421-41-GBniversity of Oxford136
招募中
不适用
Targeting Complete Response in Younger transplant-eligible Multiple myeloma patients with Bortezomib and Lenalidomide treatment after relapse with autologous stem cell transplantatiomultiple myelomaJPRN-UMIN000013704Division of Hematology, Saitama Medical Center, Jichi Medical University41
已完成
不适用
Vaccination with minor histocompatibility antigen-loaded donor DC vaccines to boost graft-versus-tumor immunity after allogeneic stem cell transplantation (a phase I study)blood cell cancerhematological malignancies10027656NL-OMON40014niversitair Medisch Centrum Sint Radboud10
进行中（未招募）
1 期
Dendritic cells vaccination after allogeneic stem cell transplantatioPatients with aggressive hematological malignancies treated with allogeneic stem cell transplantationEUCTR2012-002879-34-NLRadboud University Nijmegen Medical Centre